Evidence map›Paper›PMID 36851057›Full record

ArticleToxics2023

A Proposed Association between Improving Energy Metabolism of HepG2 Cells by Plant Extracts and Increasing Their Sensitivity to Doxorubicin.

Tamer A Al-Shafie, Engy A Mahrous, Mustafa Shukry, Mohammad Y Alshahrani, Samah F Ibrahim, Liana Fericean, Afaf Abdelkader, Mennatallah A Ali

Open access · goldAbstract read
In one paragraph

Article in Toxics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Frontiers in pharmacology · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 3 countries.

Tamer A Al-ShafieFaculty of Dentistry, Biochemistry Department, Pharos University in Alexandria, Alexandria 21532, Egypt.ORCID 0000-0001-9179-697X
Engy A MahrousFaculty of Pharmacy, Pharmacognosy Department, Cairo University, Cairo 11435, Egypt.
Mustafa ShukryFaculty of Veterinary Medicine, Department of Physiology, Kafrelsheikh University, Kafrelsheikh 33516, Egypt.ORCID 0000-0003-2722-2466
Mohammad Y AlshahraniResearch Center for Advanced Materials Science (RCAMS), King Khalid University, P.O. Box 9004, Abha 61413, Saudi Arabia.ORCID 0000-0002-7096-0221
Samah F IbrahimDepartment of Clinical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0002-2824-3296
Liana FericeanFaculty of Agriculture, Department of Biology and Plant Protection, University of Life Sciences "King Michael I" from Timișoara, Calea Aradului 119, CUI 3487181, 300645 Timisoara, Romania.
Afaf AbdelkaderFaculty of Medicine, Department of Forensic Medicine and Clinical Toxicology, Benha University, Benha 13518, Egypt.ORCID 0000-0002-0460-3402
Mennatallah A AliFaculty of Pharmacy, Pharmacology and Therapeutics Department, Pharos University in Alexandria, Alexandria 21532, Egypt.ORCID 0000-0003-0732-924X
Pharos University in Alexandria · EGBenha University · EGCairo University · EGKafrelsheikh University · EGKing Khalid University · SAPrincess Nourah bint Abdulrahman University · SAUnivesity of Life Science "King Mihai I" from Timisoara · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing cancer cell sensitivity to chemotherapy by amending aberrant metabolism using plant extracts represents a promising strategy to lower chemotherapy doses while retaining the same therapeutic outcome. Here, we incubated HepG2 cells with four plant extracts that were selected based on an earlier assessment of their cytotoxicity, viz asparagus, green tea, rue, and avocado, separately, before treatment with doxorubicin. MTT assays elucidated a significant decrease in doxorubicin-IC

Indexed as

asparagusavocadocancer metabolismdoxorubicingreen teaHepG2 cells sensitizationrue

Identifiers

PMID36851057
PMCPMC9967676
OpenAlexW4321092869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.